189 related articles for article (PubMed ID: 23483195)
1. Expression of HAUSP in gliomas correlates with disease progression and survival of patients.
Cheng C; Niu C; Yang Y; Wang Y; Lu M
Oncol Rep; 2013 May; 29(5):1730-6. PubMed ID: 23483195
[TBL] [Abstract][Full Text] [Related]
2. HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG.
Cheng CD; Dong YF; Niu WX; Niu CS
Pathol Res Pract; 2020 Apr; 216(4):152883. PubMed ID: 32088087
[TBL] [Abstract][Full Text] [Related]
3. HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.
Bhattacharya S; Ghosh MK
FEBS J; 2014 Jul; 281(13):3061-78. PubMed ID: 24823443
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
Xu Y; Yuan J; Zhang Z; Lin L; Xu S
Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of FAT10 is correlated with progression and prognosis of human glioma.
Yuan J; Tu Y; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
Pathol Oncol Res; 2012 Oct; 18(4):833-9. PubMed ID: 22402871
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients.
He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
J Exp Clin Cancer Res; 2011 Jul; 30(1):70. PubMed ID: 21791112
[TBL] [Abstract][Full Text] [Related]
8. Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity.
Lee KW; Cho JG; Kim CM; Kang AY; Kim M; Ahn BY; Chung SS; Lim KH; Baek KH; Sung JH; Park KS; Park SG
J Biol Chem; 2013 Nov; 288(46):32886-96. PubMed ID: 24072712
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of a disintegrin and metalloproteinase-17 in patients with gliomas.
Wu B; Sha L; Wang Y; Xu W; Yu Y; Feng F; Sun C; Xia L
Oncol Lett; 2014 Dec; 8(6):2616-2620. PubMed ID: 25364437
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
12. Expression of ADP-ribosyltransferase 1 Is Associated with Poor Prognosis of Glioma Patients.
Li Z; Yan X; Sun Y; Yang X
Tohoku J Exp Med; 2016 Aug; 239(4):269-78. PubMed ID: 27466078
[TBL] [Abstract][Full Text] [Related]
13. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
14. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomas.
Liu C; Tu Y; Yuan J; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
J Biomed Biotechnol; 2012; 2012():760679. PubMed ID: 22496614
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
Men D; Liang Y; Chen L
Cancer Epidemiol; 2014 Apr; 38(2):152-6. PubMed ID: 24559637
[TBL] [Abstract][Full Text] [Related]
17. Expression level of human miR-34a correlates with glioma grade and prognosis.
Gao H; Zhao H; Xiang W
J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
[TBL] [Abstract][Full Text] [Related]
18. Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance.
Wang H; Wu W; Wang HW; Wang S; Chen Y; Zhang X; Yang J; Zhao S; Ding HF; Lu D
Neuro Oncol; 2010 Jul; 12(7):679-86. PubMed ID: 20164241
[TBL] [Abstract][Full Text] [Related]
19. CD24 expression as a marker for predicting clinical outcome in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
J Biomed Biotechnol; 2012; 2012():517172. PubMed ID: 22500096
[TBL] [Abstract][Full Text] [Related]
20. Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
Hu Q; Huang K; Tao C; Zhu X
J Cell Mol Med; 2020 May; 24(10):5888-5900. PubMed ID: 32301283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
